194 related articles for article (PubMed ID: 10981291)
21. Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo.
Hanada M; Noguchi T; Yamaoka T
Cancer Sci; 2007 Mar; 98(3):447-54. PubMed ID: 17214744
[TBL] [Abstract][Full Text] [Related]
22. [New promising anticancer drugs for lung cancer].
Ariyoshi Y; Sugiura T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2578-84. PubMed ID: 7979416
[TBL] [Abstract][Full Text] [Related]
23. New directions for chemotherapy in non-small-cell lung cancer.
Green MR
Chest; 1993 Apr; 103(4 Suppl):370S-372S. PubMed ID: 8096453
[TBL] [Abstract][Full Text] [Related]
24. [New anti-cancer agents--from cytotoxic systemic chemotherapy to target-based agents].
Yokoba M; Yanase N; Masuda N
Gan To Kagaku Ryoho; 2005 Jun; 32(6):783-8. PubMed ID: 15984516
[TBL] [Abstract][Full Text] [Related]
25. Treatment of extensive stage small cell lung cancer.
Kelly K
Cancer Treat Res; 2001; 105():253-76. PubMed ID: 11224990
[TBL] [Abstract][Full Text] [Related]
26. [Current perspectives of new agents in lung cancer].
Fukuoka M
Nihon Rinsho; 2000 May; 58(5):1103-10. PubMed ID: 10824557
[TBL] [Abstract][Full Text] [Related]
27. The role of radiation, with or without chemotherapy, in the management of NSCLC.
Chakravarthy A; Johnson D; Choy H
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):93-100. PubMed ID: 10550832
[TBL] [Abstract][Full Text] [Related]
28. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
Mavroudis D
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
[No Abstract] [Full Text] [Related]
29. Irinotecan in advanced lung cancer: focus on North American trials.
Langer CJ
Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):17-28. PubMed ID: 15255164
[TBL] [Abstract][Full Text] [Related]
30. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?
Ferrigno D; Buccheri G
Lung Cancer; 2000 Aug; 29(2):91-104. PubMed ID: 10963840
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy in metastatic non-small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):15-27. PubMed ID: 10981287
[TBL] [Abstract][Full Text] [Related]
32. A retrospective analysis of non-platinum-based first- and second-line chemotherapy in patients with advanced non-small cell lung cancer.
Kotsakis A; Hatzidaki D; Vamvakas L; Vardakis N; Kalykaki A; Bozionelou V; Androulakis N; Kalbakis K; Saridaki Z; Georgoulias V; Agelaki S
Anticancer Res; 2010 Oct; 30(10):4335-42. PubMed ID: 21036760
[TBL] [Abstract][Full Text] [Related]
33. [Outpatient chemotherapy for lung cancer].
Yoneda S
Gan To Kagaku Ryoho; 2007 Apr; 34(4):533-7. PubMed ID: 17431337
[TBL] [Abstract][Full Text] [Related]
34. Time-Series Modeling and Simulation for Comparative Cost-Effective Analysis in Cancer Chemotherapy: An Application to Platinum-Based Regimens for Advanced Non-small Cell Lung Cancer.
Chisaki Y; Nakamura N; Yano Y
Biol Pharm Bull; 2017; 40(1):73-81. PubMed ID: 28049952
[TBL] [Abstract][Full Text] [Related]
35. The role of new agents in advanced non-small-cell lung carcinoma.
Langer CJ
Curr Oncol Rep; 2000 Jan; 2(1):76-89. PubMed ID: 11122828
[TBL] [Abstract][Full Text] [Related]
36. [Combination chemotherapy in the treatment of inoperable non-small cell lung cancer].
Masuda N
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():379-83. PubMed ID: 9369911
[TBL] [Abstract][Full Text] [Related]
37. Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
Rigas JR
Semin Oncol; 2001 Jun; 28(3 Suppl 9):15-20. PubMed ID: 11441410
[TBL] [Abstract][Full Text] [Related]
38. Chemoresistance in non-small cell lung cancer.
Sève P; Dumontet C
Curr Med Chem Anticancer Agents; 2005 Jan; 5(1):73-88. PubMed ID: 15720263
[TBL] [Abstract][Full Text] [Related]
39. Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Erland JB; Baker M; Scullin DC; Shaffer DW; Greco FA;
Cancer Invest; 2003 Apr; 21(2):193-9. PubMed ID: 12743984
[TBL] [Abstract][Full Text] [Related]
40. [Maintenance chemotherapy in advanced NSCLC].
Krazkowski M
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S16-8. PubMed ID: 16719150
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
